Suppliers / Bhageria And Jajodia Pharmaceuticals

Bhageria And Jajodia Pharmaceuticals

India Updated 9 July 2026

Bhageria And Jajodia Pharmaceuticals is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $17K of exports covering 3 molecules to 1 destination in 2025.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Mecobalamin US FDA 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2025 Not reported $17K 1
2024 Not reported $4K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Bhageria And Jajodia Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts